Department of Radiation Oncology, University of Louisville School of Medicine, 529 S Jackson St, Ste 400, Louisville, KY 40202, USA; James Graham Brown Cancer Center, 529 S Jackson St, Louisville, KY 40202, USA.
Department of Otolaryngology-Head and Neck Surgery and Communicative Disorders, University of Louisville School of Medicine, 529 S Jackson St, Third Floor, Louisville, KY 40202, USA; James Graham Brown Cancer Center, 529 S Jackson St, Louisville, KY 40202, USA.
Oral Oncol. 2019 Jan;88:85-90. doi: 10.1016/j.oraloncology.2018.11.024. Epub 2018 Nov 22.
To determine predictors of treatment selection, outcome, and survival, we examined a cohort of previously irradiated head and neck squamous cell carcinoma (HNSCC) patients.
We retrospectively analyzed 100 patients at our institution who were treated for recurrent or second primary (RSP) HNSCC, focusing on subgroups receiving reirradiation (ReRT) alone and those undergoing surgical salvage (SS) with or without post-operative reirradiation therapy (POReRT). Logistic regression modeling was performed to identify factors predictive of retreatment modality. Cox regression modeling was used to determine prognostic factors for progression free survival (PFS) and overall survival (OS).
ReRT alone was less likely in current smokers and neck recurrences, with reirradiation more likely in primary site recurrences. POReRT was significantly more likely in patients with positive surgical margins (PSM), neck dissection, or organ dysfunction. POReRT omission negatively impacted PFS when PSM (HR: 8.894, 95% CI: 1.742-45.403) and perineural invasion (PNI) (HR: 3.391, 95% CI: 1.140-10.089) were present. Tracheostomy was associated with worse OS, but ReRT alone and POReRT improved OS. PSM correlated with worse OS, regardless of whether POReRT was given (HR: 14.260, 95% CI: 2.064-98.547).
This analysis confirms known factors for predicting outcome and shows nonsmoking status and primary site recurrence as predictors for ReRT alone. POReRT for PSM and PNI improves PFS. Tracheostomy patients are more likely to have ReRT due to acute toxicity not limiting treatment and POReRT improves OS compared to surgery alone. The presence of PSM negatively impacts survival which cannot be overcome by POReRT.
为了确定治疗选择、结果和生存的预测因素,我们检查了一组先前接受过放疗的头颈部鳞状细胞癌(HNSCC)患者。
我们回顾性分析了我院 100 例接受复发性或第二原发(RSP)HNSCC 治疗的患者,重点关注单独接受再放疗(ReRT)和接受手术挽救(SS)加或不加术后再放疗(POReRT)的亚组。采用逻辑回归模型确定预测再治疗方式的因素。采用 Cox 回归模型确定无进展生存期(PFS)和总生存期(OS)的预后因素。
目前吸烟和颈部复发患者更倾向于单独接受 ReRT,而原发部位复发患者更倾向于接受再放疗。存在阳性手术切缘(PSM)、颈部清扫术或器官功能障碍的患者更有可能接受 POReRT。当存在 PSM(HR:8.894,95%CI:1.742-45.403)和神经周围侵犯(PNI)(HR:3.391,95%CI:1.140-10.089)时,不进行 POReRT 会显著影响 PFS。气管造口术与 OS 较差相关,但单独接受 ReRT 和 POReRT 可改善 OS。PSM 与 OS 较差相关,无论是否给予 POReRT(HR:14.260,95%CI:2.064-98.547)。
这项分析证实了预测结果的已知因素,并表明非吸烟状态和原发部位复发是单独接受 ReRT 的预测因素。对于 PSM 和 PNI,给予 POReRT 可改善 PFS。由于急性毒性不会限制治疗,气管造口术患者更有可能接受 ReRT,并且与单独手术相比,POReRT 可改善 OS。PSM 的存在对生存产生负面影响,无法通过 POReRT 克服。